KDDIY INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving KDDI Corporation

NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / (ACCESS NEWSWIRE)-The law firm of Kirby McInerney LLP continues its investigation on behalf of KDDI Corporation ("KDDI" or the "Company") (OTC:KDDIY) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. […]

Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Mereo BioPharma Group plc – MREO

NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ:MREO).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail

Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Richtech Robotics Inc. – RR

NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Richtech Robotics Inc. ("Richtech" or the "Company") (NASDAQ:RR).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Pomerantz LLP Calls Attention to Class Action Involving uniQure N.V. – QURE

NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against uniQure N.V. ("uniQure" or the "Company") (NASDAQ:QURE).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Pomerantz LLP Informs Investors of Class Action Against PomDoctor Ltd. – POM

NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against PomDoctor Ltd. ("PomDoctor" or the "Company") (NASDAQ:POM).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Pomerantz LLP Informs Investors of Class Action Against Ultragenyx Pharmaceutical Inc. – RARE

NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ:RARE).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Early Warning News Release

This press release is issued pursuant to Multilateral Instrument 62-104 – Take-Over Bids and Issuer Bids and National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues. Calgary, Alberta–(Newsfile Corp. – February 27, 2026) – Mr. Ryan Kalt (the “Acquiror“) reports that he has divested certain securities of Red

Class Action Lawsuit Filed by Pomerantz LLP for Investors of CoreWeave, Inc. – CRWV

NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against CoreWeave, Inc. ("CoreWeave" or the "Company") (NASDAQ:CRWV) and certain officers.�� The class action, filed in the United States District Court for the Western District of Texas, and docketed under 26-cv-00355, is

TrustBIX Inc. Announces December 31, 2025 First Quarter Financial Results

Edmonton, Alberta–(Newsfile Corp. – February 27, 2026) – TrustBIX Inc. (TSXV: TBIX) (“TrustBIX” or the “Company”) announced today financial results for the first quarter ended December 31, 2025, and the related Management’s Discussion and Analysis (“MD&A”). For the three months ended December 31, 2025, compared to the same period in 2024, the Company reported results from continuing

Class Action Lawsuit Reminder from Pomerantz LLP for Shareholders of Varonis Systems, Inc. – VRNS

NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ:VRNS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Scroll to Top